{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:52:12Z","timestamp":1781923932169,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.tiv.2014.07.015","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T09:26:13Z","timestamp":1409563573000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"PA","title":["The in vitro biokinetics of chlorpromazine and diazepam in aggregating rat brain cell cultures after repeated exposure"],"prefix":"10.1016","volume":"30","author":[{"given":"Jessica J.W.","family":"Broeders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop L.M.","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas J.","family":"Blaauboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Gabrielle","family":"Zurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2014.07.015_b0005","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1023\/A:1013358126640","article-title":"Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein","volume":"18","author":"Adachi","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2014.07.015_b0010","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2014.07.015_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines \u2013 when and what to use","volume":"48","author":"Ashton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.tiv.2014.07.015_b0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ntt.2008.12.003","article-title":"Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered","volume":"32","author":"Bal-Price","year":"2010","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.tiv.2014.07.015_b0025","first-page":"495","article-title":"Fifty years chlorpromazine: a historical perspective","volume":"3","author":"Ban","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.tiv.2014.07.015_b0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.14573\/altex.2012.4.411","article-title":"The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans","volume":"29","author":"Blaauboer","year":"2012","journal-title":"ALTEX"},{"key":"10.1016\/j.tiv.2014.07.015_b0035","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1016\/j.chroma.2011.09.064","article-title":"Development of a negligible depletion-solid phase microextraction method to determine the free concentration of chlorpromazine in aqueous samples containing albumin","volume":"1218","author":"Broeders","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tiv.2014.07.015_b0040","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/tx300221k","article-title":"Transport of chlorpromazine in the Caco-2 cell permeability assay: a kinetic study","volume":"25","author":"Broeders","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2014.07.015_b0045","doi-asserted-by":"crossref","unstructured":"Broeders, J.J.W., Parmentier, C., Truisi, G.L., Joss\u00e9, R., Alexandre, E., Savary, C., Hewitt, P.G., Mueller, S.O., Guillouzo, A., Richert, L., van Eijkeren, J.C.H., Hermens, J.L.M., Blaauboer, B.J., 2015. Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure. Toxicol. In Vitro 30, 52\u201361.","DOI":"10.1016\/j.tiv.2014.08.012"},{"key":"10.1016\/j.tiv.2014.07.015_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.etap.2005.07.006","article-title":"The value of alternative testing for neurotoxicity in the context of regulatory needs","volume":"21","author":"Coecke","year":"2006","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.tiv.2014.07.015_b0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1289\/ehp.98106505","article-title":"Neurotoxicity testing: a discussion of in vitro alternatives","volume":"106","author":"Costa","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2014.07.015_b0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro p-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2014.07.015_b0065","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.tiv.2009.07.017","article-title":"Neuronal in vitro models for the estimation of acute systemic toxicity","volume":"23","author":"Forsby","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.07.015_b0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999\u2217","volume":"35","author":"Fung","year":"2001","journal-title":"Drug Inf. J."},{"key":"10.1016\/j.tiv.2014.07.015_b0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tiv.2004.06.011","article-title":"In vitro models for the blood\u2013brain barrier","volume":"19","author":"Garberg","year":"2005","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.07.015_b0080","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(06)69665-7","article-title":"Developmental neurotoxicity of industrial chemicals","volume":"368","author":"Grandjean","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tiv.2014.07.015_b0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.aquatox.2005.02.002","article-title":"Impact of bioavailability on the correlation between in vitro cytotoxic and in vivo acute fish toxic concentrations of chemicals","volume":"72","author":"G\u00fclden","year":"2005","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.tiv.2014.07.015_b0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0300-483X(02)00085-9","article-title":"Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro","volume":"175","author":"G\u00fclden","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2014.07.015_b0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2014.07.015_b0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1517\/17425255.1.4.701","article-title":"Evaluation of neurotoxic potential by use of in vitro systems","volume":"1","author":"Harry","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.tiv.2014.07.015_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1289\/ehp.98106s1131","article-title":"In vitro techniques for the assessment of neurotoxicity","volume":"106","author":"Harry","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2014.07.015_b0110","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1021\/es049285w","article-title":"Toward more useful in vitro toxicity data with measured free concentrations","volume":"38","author":"Heringa","year":"2004","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tiv.2014.07.015_b0115","series-title":"Cell Culture Techniques","first-page":"105","article-title":"Preparation and use of serum-free aggregating brain cell cultures for routine neurotoxicity screening","author":"Honegger","year":"2011"},{"key":"10.1016\/j.tiv.2014.07.015_b0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/282305a0","article-title":"Growth and differentiation of aggregating fetal brain cells in a serum-free defined medium","volume":"282","author":"Honegger","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.tiv.2014.07.015_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2006.12.004","article-title":"Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood\u2013brain barrier","volume":"56","author":"Jolliet","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tiv.2014.07.015_b0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0005-2760(89)90078-7","article-title":"Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis","volume":"1004","author":"Joshi","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.07.015_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0270(87)90041-0","article-title":"Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay","volume":"20","author":"Koh","year":"1987","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.tiv.2014.07.015_b0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/tx200479k","article-title":"Quantifying the processes that determine the free concentration of phenanthrene in a basal cytotoxicity assay","volume":"25","author":"Kramer","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2014.07.015_b0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000111363","article-title":"Glial hyaluronate-binding protein expression in aggregating brain cell cultures","volume":"15","author":"Monnet-Tschudi","year":"1993","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.tiv.2014.07.015_b0150","unstructured":"OECD, 1997. OECD guideline for the testing of chemicals nr. 424: Neurotoxicity study in rodents. <http:\/\/www.oecd-library.org\/environment\/testno424neurotoxicitystudyinrodents_9789264071025.en> (accessed 25.01.13)."},{"key":"10.1016\/j.tiv.2014.07.015_b0155","unstructured":"OECD, 2007. OECD guideline for the testing of chemicals nr. 426: Developmental neurotoxicity study. <http:\/\/www.oecd-library.org\/environment\/testno426developmental neurotoxicitystudy_9789264067394.en> (accessed 25.01.13)."},{"key":"10.1016\/j.tiv.2014.07.015_b0160","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1023\/A:1016217505990","article-title":"Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine","volume":"12","author":"Saitoh","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2014.07.015_b0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1018916027099","article-title":"Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning","volume":"11","author":"Sawada","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2014.07.015_b0170","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0731-7085(96)01773-6","article-title":"Interlaboratory study of log P determination by shake-flask and potentiometric methods","volume":"14","author":"Tak\u00e1cs-Nov\u00e1k","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tiv.2014.07.015_b0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)32167-1","article-title":"Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver","volume":"214","author":"Tavoloni","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2014.07.015_b0180","unstructured":"Van der Jagt, K., Munn, S., T\u01ffrsl\u01ffv, J., de Bruijn, J., 2004. Alternative approaches can reduce the use of test animals under REACH. Report EUR 21405."},{"key":"10.1016\/j.tiv.2014.07.015_b0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-006-0437-9","article-title":"Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein","volume":"187","author":"Wang","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tiv.2014.07.015_b0190","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1023\/A:1012102522787","article-title":"In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man \u2013 fact or myth","volume":"14","author":"Yee","year":"1997","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.tiv.2014.07.015_b0195","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3109\/10408444.2012.692115","article-title":"Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results","volume":"42","author":"Yoon","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2014.07.015_b0200","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.tiv.2012.06.018","article-title":"Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity","volume":"27","author":"Zurich","year":"2012","journal-title":"Toxicol. In Vitro"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T12:19:29Z","timestamp":1746361169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233314001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0887233314001581"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2014.07.015","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The in vitro biokinetics of chlorpromazine and diazepam in aggregating rat brain cell cultures after repeated exposure","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2014.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}